“…A provider initiating a pediatric patient on an SSRI needs to know which drug, if any, may have a greater risk of adverse cardiac events than another. Yet, there have been no pediatric‐focused studies examining the association between SSRI use and either prolonged QT or TdP outside of clear overdose situations or antenatal exposure . Therefore, given the paucity of pediatric data and the frequency with which SSRIs are prescribed for children and adolescents, we performed a comparative safety study examining the risk of ventricular arrhythmias, cardiac arrest, or sudden death (VA, CA, or SD) associated with SSRI use in pediatric population.…”